Marta Wojno

Marta Wojno

Auto-generated profile, based on publicly available information

Marta Wojno

VIB-KU Leuven Center for Brain & Disease Research, CBD Technologies, Single Cell & Microfluidics Expertise Unit, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2025 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
GAGiulia Albertini
Giulia Albertini
MZMagdalena Zielonka
Magdalena Zielonka
MCMarie-Lynn Cuypers
Marie-Lynn Cuypers
ASAn Snellinx
An Snellinx
CXCiana Xu
Ciana Xu
BSBart De Strooper
Bart De Strooper
Controversies over anti-amyloid immunotherapies underscore the need to elucidate their mechanisms of action. Here we demonstrate that Lecanemab, a leading anti-β-amyloid (Aβ) antibody, mediates amyloid clearance by activating microglial effector functions. Using a human microglia xenograft mouse model, we show that Lecanemab significantly reduces Aβ pathology and associated neuritic damage, while neither fragment crystallizable (Fc)-silenced Lecanemab nor microglia deficiency elicits this effect despite intact plaque binding. Single-cell RNA sequencing and spatial transcriptomic analyses reveal that Lecanemab induces a focused transcriptional program that enhances phagocytosis, lysosomal degradation, metabolic reprogramming, interferon γ genes and antigen presentation. Finally, we identify SPP1 /osteopontin as a major factor induced by Lecanemab treatment and demonstrate its role in promoting Aβ clearance. These findings highlight that effective amyloid removal depends on the engagement of microglia through the Fc fragment, providing critical insights for optimizing anti-amyloid therapies in Alzheimer’s disease.

4 November 2022 in Neuron
Verified
Journal Article
Open access
RHRoxane Van Heurck
Roxane Van Heurck
JBJérôme Bonnefont
Jérôme Bonnefont
MWMarta Wojno
Marta Wojno
ISIkuo K. Suzuki
Ikuo K. Suzuki
FVFausto D. Velez-Bravo
Fausto D. Velez-Bravo
PVPierre Vanderhaeghen
Pierre Vanderhaeghen
The primary cilium is a central signaling component during embryonic development. Here we focus on CROCCP2, a hominid-specific gene duplicate from ciliary rootlet coiled coil (CROCC), also known as rootletin, that encodes the major component of the ciliary rootlet. We find that CROCCP2 is highly expressed in the human fetal brain and not in other primate species. CROCCP2 gain of function in the mouse embryonic cortex and human cortical cells and organoids results in decreased ciliogenesis and increased cortical progenitor amplification, particularly basal progenitors. CROCCP2 decreases ciliary dynamics by inhibition of the IFT20 ciliary trafficking protein, which then impacts neurogenesis through increased mTOR signaling. Loss of function of CROCCP2 in human cortical cells and organoids leads to increased ciliogenesis, decreased mTOR signaling, and impaired basal progenitor amplification. These data identify CROCCP2 as a human-specific modifier of cortical neurogenesis that acts through modulation of ciliary dynamics and mTOR signaling.

22 January 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
HDHannah Dickmänken
Hannah Dickmänken
MWMarta Wojno
Marta Wojno
LMLukas Mahieu
Lukas Mahieu
KTKoen Theunis
Koen Theunis
EEEren Can Ekşi
Eren Can Ekşi
SAStein Aerts
Stein Aerts
Deciphering the cis-regulatory logic underlying cell type identity remains a key challenge in biology. Single-cell chromatin accessibility (scATAC-seq) atlases enable training of sequence-to-function (S2F) deep learning models to decode enhancer logic. Yet, optimal criteria for constructing training datasets, i.e., the number of cells and ATAC fragments, remain unclear. Moreover, the suitability of different scATAC-seq platforms for such models has not been systematically tested. We introduce HyDrop v2, an improved custom droplet scATAC-seq method, and perform the first benchmark of scATAC-seq platforms focusing on its capacity to train S2F models and its capacity to yield TF footprints in different species. We show that lower fragment counts can be compensated for by increased cell numbers. S2F models trained on custom or commercial data perform comparably in enhancer prediction, sequence explainability, and transcription factor footprinting. We demonstrate that integrating data from different scATAC-seq platforms enables large-scale, cost-efficient atlas construction for deep learning-based regulatory modeling.

3 December 2025 in bioRxiv
Verified
Preprint
Open access
SKSam S.F.A. van Knippenberg
Sam S.F.A. van Knippenberg
MTMaria Tryfonos
Maria Tryfonos
JBJoke De Busscher
Joke De Busscher
EBElena Biondi
Elena Biondi
MSMairim Alexandra Solis
Mairim Alexandra Solis
Vincent PasqueVincent Pasque
Vincent Pasque
Gene regulatory networks establish cell identity during development by regulating transcription factor binding at cis-regulatory elements, many of which require chromatin remodelers for accessibility. Although these key principles of gene regulation in mammalian development have emerged, the contribution of chromatin remodellers to early human embryogenesis remains unclear. Here, we show that the SWI/SNF ATPases SMARCA2 and SMARCA4 are essential for establishing gene regulatory programs and cell identity in human pre-implantation development by facilitating enhancer accessibility. Using both human blastoids and human blastocysts, we find that loss of SMARCA2/4 disrupts blastoid epiblast identity, enhances trophectoderm initiation, and impairs inner cell mass formation and developmental progression. Integrative single-cell chromatin accessibility and transcriptome profiling in blastoids reveals that SMARCA2/4 safeguard naïve epiblast and trophectoderm programs by maintaining enhancer and transcription factor binding motif accessibility. These findings identify SWI/SNF chromatin remodellers as critical regulators of embryonic lineage specification during human pre-implantation development.

10 September 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
KCKatrien De Clercq
Katrien De Clercq
VPVicente Pérez-García
Vicente Pérez-García
APAmitesh Panda
Amitesh Panda
SGSeppe Gevaert
Seppe Gevaert
JWJill Witvrouwen
Jill Witvrouwen
JVJoris Vriens
Joris Vriens
While placental functioning arbitrates fetal outcome, the molecular players that underpin normal placental development remain poorly understood. Here, we provide evidence that the Transient Receptor Potential Vanilloid 2 (TRPV2) channel plays an important role in normal placental development, determining fetal size and survival. Its absence severely affects placental morphology, causing fetal growth restriction and embryonic lethality, which was found to be allocated to a non-redundant role in the trophoblast, but not in the embryo. CRISPR/Cas9-mediated Trpv2 deletion in mouse trophoblast stem cells demonstrated that Trpv2 contributes to the differentiation towards Syncytiotrophoblast layer II (SynTII) cells, which was confirmed by the growth restriction phenotype in SynTII-specific Trpv2 knockout animals. Finally, TRPV2 was functionally expressed in human trophoblast cells and enriched in trophoblast populations undergoing syncytial differentiation. Together, our findings identify an important role for TRPV2 during placental development and consequently fetal outcomes.

4 April 2025 in bioRxiv
Verified
Preprint
Open access
HDHannah Dickmänken
Hannah Dickmänken
MWMarta Wojno
Marta Wojno
KTKoen Theunis
Koen Theunis
EEEren Can Ekşi
Eren Can Ekşi
LMLukas Mahieu
Lukas Mahieu
SAStein Aerts
Stein Aerts
Summary: Deciphering cis-regulatory logic underlying cell type identity is a fundamental question in biology. Single-cell chromatin accessibility (scATAC-seq) data has enabled training of sequence-to-function deep learning models allowing decoding of enhancer logic and design of synthetic enhancers. Training such models requires large amounts of high-quality training data across species, organs, development, aging, and disease. To facilitate the cost-effective generation of large scATAC-seq atlases for model training, we developed a new version of the open-source microfluidic system HyDrop with increased sensitivity and scale: HyDrop v2. We generated HyDrop v2 atlases for the mouse cortex and Drosophila embryo development and compared them to atlases generated on commercial platforms. HyDrop v2 data integrates seamlessly with commercially available chromatin accessibility methods (10x Genomics). Differentially accessible regions and motif enrichment across cell types are equivalent between HyDrop-v2 and 10x atlases. Sequence-to-function models trained on either atlas are comparable as well in terms of enhancer predictions, sequence explainability, and transcription factor footprinting. By offering accessible data generation, enhancer models trained on HyDrop-v2 and mixed atlases can contribute to unraveling cell-type specific regulatory elements in health and disease.